Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M V Papadopoulou
The Hypoxia-Selective Cytotoxin NLCQ-1 (NSC 709257) Controls Metastatic Disease When Used as an Adjuvant to Radiotherapy
British Journal of Cancer
Cancer Research
Oncology
Related publications
The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
TLR9 Agonist, but Not TLR7/8, Functions as an Adjuvant to Diminish FI-RSV Vaccine-Enhanced Disease, While Either Agonist Used as Therapy During Primary RSV Infection Increases Disease Severity
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns
Clinical Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Overcoming Tumor Hypoxia as a Barrier to Radiotherapy, Chemotherapy and Immunotherapy in Cancer Treatment
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy
Viruses
Virology
Infectious Diseases
The RNA-Binding Protein RBM3 Promotes Neural Stem Cell (NSC) Proliferation Under Hypoxia
Frontiers in Cell and Developmental Biology
Developmental Biology
Cell Biology
Hypercalcemia Caused by Metastatic Adamantinoma: Response to Radiotherapy
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
Spironolactone as an Adjuvant to the Treatment of Congestive Cardiac Failure
Postgraduate Medical Journal
Medicine
Higher Muscle Tissue Oxygenation When Exposed to Hypobaric Hypoxia Than Normobaric Hypoxia
Journal of Human Performance in Extreme Environments
